diclofenac and uridine triphosphate

diclofenac has been researched along with uridine triphosphate in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Amblard, F; Bassit, LC; Cho, JH; Coats, SJ; De Schutter, C; Domaoal, RA; Ehteshami, M; Jiang, Y; Kasthuri, M; Lee, S; Lin, BY; McBrayer, T; Mengshetti, S; Ollinger Russell, O; Ovadia, R; Pascual, ML; Pattassery, J; Sari, O; Schinazi, RF; Tao, S; Uher, L; Verma, K; Whitaker, T; Zhang, H; Zhou, L	1
Bendavit, GG; Cohen, JC; Geller, M; Higashi, R; Mibielli, MA; Nunes, CP; Oliveira, L; Scussel, AB	1

Trials

1 trial(s) available for diclofenac and uridine triphosphate

Article	Year
Treatment of acute, non-traumatic pain using a combination of diclofenac-cholestyramine, uridine triphosphate, cytidine monophosphate, and hydroxycobalamin. Proceedings of the Western Pharmacology Society, 2010, Volume: 53 Topics: Acute Disease; Adult; Anti-Inflammatory Agents, Non-Steroidal; Cholestyramine Resin; Cytidine Monophosphate; Diclofenac; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydroxocobalamin; Male; Middle Aged; Pain; Uridine Triphosphate	2010

Article

Year

Treatment of acute, non-traumatic pain using a combination of diclofenac-cholestyramine, uridine triphosphate, cytidine monophosphate, and hydroxycobalamin.

Proceedings of the Western Pharmacology Society, 2010, Volume: 53

Topics: Acute Disease; Adult; Anti-Inflammatory Agents, Non-Steroidal; Cholestyramine Resin; Cytidine Monophosphate; Diclofenac; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydroxocobalamin; Male; Middle Aged; Pain; Uridine Triphosphate

2010

Other Studies

1 other study(ies) available for diclofenac and uridine triphosphate

Article	Year
Discovery of a Series of 2'-α-Fluoro,2'-β-bromo-ribonucleosides and Their Phosphoramidate Prodrugs as Potent Pan-Genotypic Inhibitors of Hepatitis C Virus. Journal of medicinal chemistry, 2019, 02-28, Volume: 62, Issue:4 Topics: Animals; Antiviral Agents; Cell Line, Tumor; Deoxyribonucleosides; Deoxyuracil Nucleotides; Dogs; Drug Discovery; Enzyme Inhibitors; Hepacivirus; Humans; Male; Microsomes, Liver; Prodrugs; Viral Nonstructural Proteins	2019

Article

Year

Discovery of a Series of 2'-α-Fluoro,2'-β-bromo-ribonucleosides and Their Phosphoramidate Prodrugs as Potent Pan-Genotypic Inhibitors of Hepatitis C Virus.

Journal of medicinal chemistry, 2019, 02-28, Volume: 62, Issue:4

Topics: Animals; Antiviral Agents; Cell Line, Tumor; Deoxyribonucleosides; Deoxyuracil Nucleotides; Dogs; Drug Discovery; Enzyme Inhibitors; Hepacivirus; Humans; Male; Microsomes, Liver; Prodrugs; Viral Nonstructural Proteins

2019